Targeted radiation for lung cancer may carry risks
(HealthDay) -- A woman with early-stage lung cancer died recently after highly targeted radiation therapy zapped not just her tumor, but surrounding tissue, fatally damaging her airway.
Cancer
Jun 13, 2012 |
not rated yet |
0
New ruthenium-based drugs show promise for killing cancer cells
A new study by University of Kentucky researchers shows how light and strained ruthenium-based drugs may be more effective at fighting cancer cells and less toxic to healthy cells than a similar and widely used drug.
Cancer
Jun 11, 2012 |
5 / 5 (2) |
0
|
Cancer therapy that boosts immune system ready for wider testing
Two clinical trials led by Johns Hopkins Kimmel Cancer Center researchers in collaboration with other medical centers, testing experimental drugs aimed at restoring the immune system's ability to spot and attack cancer, have ...
Cancer
Jun 02, 2012 |
4.6 / 5 (7) |
0
|
New therapy on the horizon for ALK+ non-small cell lung cancer
A new compound that targets anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer is well-tolerated by patients and is already showing early signs of activity, including in patients who no longer respond to ...
Cancer
Jun 01, 2012 |
not rated yet |
0
|
Chemotherapy and radiation given together could help elderly patients with lung cancer live longer
Despite more than two-thirds of lung cancer cases being diagnosed in people 65 years or older, there have been few trials of treatments in this age group, and it is not known if the standard treatment for patients with inoperable ...
Cancer
May 21, 2012 |
not rated yet |
0
Stopping cell migration may help block fibrosis and the spread of cancer
(Medical Xpress) -- Discoveries by a Yale-led team of scientists could lead the way for development of new therapies for treating fibrosis and tumor metastasis. The researchers have both uncovered a signaling ...
Medical research
May 21, 2012 |
4.7 / 5 (3) |
0
|
Scientists aim to kill lung tumors
Lung cancer is the leading cause of cancer death throughout the world. Standard treatment methods do not usually result in long-term recovery. In addition to the proliferation of the tumour cells, the growth ...
Cancer
May 04, 2012 |
5 / 5 (2) |
0
|
Study identifies gene critical to development and spread of lung cancer
A single gene that promotes initial development of the most common form of lung cancer and its lethal metastases has been identified by researchers at Mayo Clinic in Florida. Their study suggests other forms of cancer may ...
Cancer
Apr 24, 2012 |
not rated yet |
0
|
Gene signature helps identify risk of relapse in lung cancer patients
A new genetic signature identified by Spanish researchers may provide doctors with robust and objective information about which patients with early stage lung cancer are at low or high risk of relapse following surgery, investigators ...
Cancer
Apr 18, 2012 |
5 / 5 (1) |
0
Avastin no benefit to older lung cancer patients: study
(HealthDay) -- Medicare patients who have advanced non-small cell lung cancer appear to get no survival benefit from adding the drug Avastin to standard chemotherapy, researchers from the Dana-Farber Cancer ...
Cancer
Apr 17, 2012 |
not rated yet |
0
|
Despite obstacles, fine needle aspiration might be best diagnostic tool
Screening for lung cancer with low dose CT scans has been shown to save lives. However, research shows that when CT scans reveal nodules in the lungs, it is not cancerous 96 percent of the time. As a result, scientists are ...
Cancer
Apr 15, 2012 |
not rated yet |
0
Researchers identified a protein useful in predicting the risk of pulmonary metastases in breast cancer patients
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have shown that breast cancer cells that metastasize to the lung express a higher level of the protein peroxiredoxin 2 (PRDX2). The study suggests that ...
Cancer
Apr 10, 2012 |
5 / 5 (1) |
0
KRAS gene mutation and amplification status affects sensitivity to antifolate therapy
Testing patients with non-small cell lung cancer for both mutations and amplifications of the KRAS gene prior to therapy may help to predict response to treatment with antifolates, according to the updated results of a preclinical ...
Cancer
Apr 04, 2012 |
not rated yet |
0
Vaccine yielded encouraging long-term survival rates in certain patients with NSCLC
Long-term follow-up of a phase II clinical trial showed encouraging survival in some patients with stage 3B/4 non-small cell lung cancer treated with belagenpumatucel-L, a therapeutic vaccine. The findings were presented ...
Cancer
Apr 04, 2012 |
not rated yet |
0
Stopping the spread of a deadly childhood bone cancer
Many children with the bone cancer, osteosarcoma, die after the tumor spreads to their lungs. In a critical step toward finding a way to stop metastasis, researchers at Georgetown Lombardi Comprehensive Cancer Center say ...
Cancer
Apr 03, 2012 |
not rated yet |
0
|
